🇺🇸 FDA
Pipeline program

Velusetrag

0048

Phase 1 small_molecule completed

Quick answer

Velusetrag for Alzheimer's Disease is a Phase 1 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Theravance Biopharma
Indication
Alzheimer's Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials